Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pulmonx (LUNG) Operating Expenses (2019 - 2025)

Pulmonx (LUNG) has disclosed Operating Expenses for 7 consecutive years, with $30.4 million as the latest value for Q3 2025.

  • Quarterly Operating Expenses rose 4.42% to $30.4 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $124.4 million through Sep 2025, up 6.28% year-over-year, with the annual reading at $119.7 million for FY2024, 6.23% up from the prior year.
  • Operating Expenses for Q3 2025 was $30.4 million at Pulmonx, down from $32.0 million in the prior quarter.
  • The five-year high for Operating Expenses was $32.0 million in Q2 2025, with the low at $19.1 million in Q1 2021.
  • Average Operating Expenses over 5 years is $26.7 million, with a median of $28.2 million recorded in 2023.
  • The sharpest move saw Operating Expenses skyrocketed 73.16% in 2021, then grew 3.37% in 2024.
  • Over 5 years, Operating Expenses stood at $22.6 million in 2021, then increased by 14.12% to $25.8 million in 2022, then increased by 9.72% to $28.3 million in 2023, then rose by 9.49% to $31.0 million in 2024, then dropped by 1.81% to $30.4 million in 2025.
  • According to Business Quant data, Operating Expenses over the past three periods came in at $30.4 million, $32.0 million, and $30.9 million for Q3 2025, Q2 2025, and Q1 2025 respectively.